Investing.com - U.S. stocks edged lower on Tuesday, as investors assessed a weaker-than-anticipated reading on consumer confidence and took some caution ahead of crucial quarterly ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...

Meanwhile, Hims & Hers (NYSE: HIMS) warned that it may stop selling legal copies of a popular weight-loss drug made by Denmark's Novo Nordisk (NYSE: NVO ), sending shares in the U.S. telehealth firm ...

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, ...

Investing.com - Hims&Hers (NYSE:HIMS) said on Monday that it may stop selling legal copies of a popular weight-loss drug made by Denmark's Novo Nordisk (NYSE:NVO), sending shares in the U.S.

Investing.com - U.S. stock futures pointed to a subdued open on Tuesday, in a sign of ongoing caution among investors ahead ...

Investing.com - Hims & Hers said on Monday that it may stop selling legal copies of a popular weight-loss drug made by Denmark's Novo Nordisk (NYSE: NVO), sending shares in the U.

Around the world, progressive parties have come to see tight immigration restrictions as unnecessary, even cruel. What if ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...